معرفی
Maicon Falavigna is an Assistant Clinical Professor (Adjunct) in the Department of Health Research Methods, Evidence, and Impact at McMaster University, Canada. A Brazilian clinical epidemiologist, he has published >200 peer-reviewed works and co-authored more than 20 national and pan-American clinical practice guidelines on COVID-19, critical care, and health policy.
Research interests
- Evidence synthesis and GRADE methodology
- COVID-19 vaccines, therapeutics and long-term sequelae
- ICU visitation policies and post-intensive-care syndrome
- Health technology assessment and rapid guideline development
- Tele-medicine and organ-donation optimisation
His 2020-2025 output is dominated by multicenter cohorts on post-COVID cardiopulmonary, cognitive and quality-of-life outcomes; RCTs of antisense therapy and convalescent plasma; real-world vaccine-effectiveness studies in children and adults; and methodological papers on scoping reviews, meta-analysis of prevalence, and plain-language dissemination. These works inform Brazilian Ministry of Health protocols and WHO/PAHO guidelines.
Guideline & policy impact
- Lead methodologist, Brazilian COVID-19 pharmacological guidelines (2020-2023)
- Pan-American Guidelines for SARS-CoV-2 treatment (2023)
- Brain-dead donor management guidelines (2021)
- Contributed to GRADE guidance papers on rapid recommendations and modeled evidence
He coordinates the multicenter Post-COVID Brazil cohorts and the DONORS organ-donation implementation trial, securing competitive grants from Brazilian research councils and international agencies. While student names are not listed in the source, he is actively involved in mentoring MSc and PhD candidates in evidence-based health care at McMaster and Brazilian universities.
